A high OSA score was strongly associated with metabolic syndrome in men (OR 6.05; 95% CI 4.23-8.69) and women (OR 4.20; 95% CI 1.23-15.70) compared to a low OSA score.
Cross-Sectional (n=7,900)
Yes
Does a high risk of obstructive sleep apnea associate with increased odds of insulin resistance and metabolic syndrome in adults?
A high risk of obstructive sleep apnea, as assessed by the simple STOP-Bang questionnaire, is strongly associated with insulin resistance and metabolic syndrome in the general adult population.
Effect estimate: OR 6.05 (95% CI 4.23-8.69)
We aimed to identify the association between obstructive sleep apnea (OSA), insulin resistance (IR), and metabolic syndrome (MetS) in a nationwide population-based sample. A total of 7,900 adults with information on the STOP-Bang score and MetS (3,341 men and 4,469 women) were identified from the dataset of the Korea National Health and Nutrition Examination Survey 2019-2020. The association between OSA, IR, MetS, and its components was estimated using complex sample logistic regression analysis with adjustments for age, body mass index, residence, smoking status, alcohol consumption, household income, education, and the presence of diabetes. Participants with a high OSA score were more likely to have IR (odds ratio OR 2.78, 95% confidence interval CI 1.96-3.95 in men and OR 2.64, 95% CI 0.55-12.80 in women), MetS (OR 6.05, 95% CI 4.23-8.69 in men and OR 4.20, 95% CI 1.23-15.70 in women), and components of MetS, compared to individuals with a low OSA score. Compared to premenopausal women, postmenopausal women had a more intense association between OSA and IR (OR 1.78, 95% CI 0.13-24.43 for premenopausal women and OR 3.64, 95% CI 0.60-22.28 for postmenopausal women) and MetS (OR 2.58, 95% CI 0.23-29.55 for premenopausal women and OR 5.36, 95% CI 1.42-20.21 for postmenopausal women). OSA was associated with abdominal obesity and hypertension in premenopausal women, while all components of MetS were associated with OSA in postmenopausal women. Further studies are necessary to elucidate the underlying mechanisms of these findings.
Kim et al. (Mon,) conducted a cross-sectional in Obstructive sleep apnea, insulin resistance, and metabolic syndrome (n=7,900). High OSA score vs. Low OSA score was evaluated on Metabolic syndrome (men) (OR 6.05, 95% CI 4.23-8.69). A high OSA score was strongly associated with metabolic syndrome in men (OR 6.05; 95% CI 4.23-8.69) and women (OR 4.20; 95% CI 1.23-15.70) compared to a low OSA score.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: